The FDA has recalled multiple lots of a blood pressure medication sold under the brand name Ziac, according to a Dec. 6 report from USA Today.
The medication — bisoprolol fumarate and hydrochlorothiazide tablets — is manufactured by Glenmark Pharmaceuticals and may have been cross-contaminated with cholesterol drug ezetimibe, the report said.
The Class III recall affects 2.5-mg to 6.25-mg dosages from the following lots, according to USA Today:
- 30-tablet bottles, NDC-68462-878-30. Lot 17232401, exp. 11/2025.
- 100-tablet bottles, NDC-68462-878-01. Lot 17232401, exp. 11/2025.
- 500-tablet bottles, NDC-68462-878-05. Lot 17232401, exp. 11/2025
- 500-tablet bottles, NDC-68462-878-05. Lot 17240974, exp. 05/2026.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.